Dynamics in emerging drug use prevalence among people who inject drugs in Ukraine between 2013 and 2017
Data Source: IBBS 2013, 2017, (N, 10000 PWIDs)
While there is no major shifting between opiate users (64%), stimulant users (12%) and mixed drugs users (24%) between 2013 and 2017. There is a significant shifting in prevalence of use of specific drugs. We compared prevalence, socio-demographic, and behavior characteristics of people who injected stimulants during last 12 month in 2103 and 2017 years.
Overall, one third of injecting drug users used stimulants during last 12 month. In 2017 we have observed the increased prevalence of use of the following stimulants: Amphetamine («fen», powder) from 12,5% to 32,3%, Methamphetamine crystallized powder from 2.8% to 5.5% and Salts (mephedrone) from 2.1 to 7.8%. The use of Methamphetamine liquid («tina», «pervitin») has been decreased form 30.3% in 2013 to 15,7% in 2017. There is no significant changes in age or sex distribution of stimulant and mixed drugs users between years. The use of other stimulants has been changed remains very low in comparison to other drugs (1-2%).
Additional data analysis: we can provide additional analysis in terms of behavior factors related to use of those drugs and in particular related specific risk behavior.
The prevalence of stimulants use among MSM in Ukraine
Data Source: IBBS 2017, (N, 5971 MSM)
Drug use among MSM is very prevalent: 56% ever used drugs and almost 20% used any drugs within last 12 months or so. Majority of those use drugs, use non-injecting drugs. The most popular drug is marijuana, 89% of those who used drugs recently (1194 respondents) used marijuana, 24% (291) used Amphetamine (fen), 54 respondents (4.5%) reported using LCD, and 4% reported using MDMA. Among those who used drugs during last 30 days (446 respondents), 70% reported having sex on drugs.
Additional data analysis: we can provide additional analysis in terms of socio-demographic and behavior factors related to use of those drugs and in particular related specific risk behavior.